Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. CME
8. HUMA
9. NVDA
10. INTC

Go back to Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results

Mersana Therapeutics (MRSN) Misses Q2 EPS by $4.71

August 13, 2025 7:05 AM EDT

Mersana Therapeutics (NASDAQ: MRSN) reported Q2 EPS of ($4.87), $4.71 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.06 million versus the consensus estimate of $6.25 million.

For earnings history and earnings-related data on Mersana Therapeutics (MRSN) click here.

... More